Increased baseline occupancy of D2 receptors by dopamine in schizophrenia - PubMed
- ️Sat Jan 01 2000
. 2000 Jul 5;97(14):8104-9.
doi: 10.1073/pnas.97.14.8104.
J Rodenhiser, D Printz, Y Zea-Ponce, R Gil, L S Kegeles, R Weiss, T B Cooper, J J Mann, R L Van Heertum, J M Gorman, M Laruelle
Affiliations
- PMID: 10884434
- PMCID: PMC16677
- DOI: 10.1073/pnas.97.14.8104
Increased baseline occupancy of D2 receptors by dopamine in schizophrenia
A Abi-Dargham et al. Proc Natl Acad Sci U S A. 2000.
Abstract
The classical dopamine hypothesis of schizophrenia postulates a hyperactivity of dopaminergic transmission at the D(2) receptor. We measured in vivo occupancy of striatal D(2) receptors by dopamine in 18 untreated patients with schizophrenia and 18 matched controls, by comparing D(2) receptor availability before and during pharmacologically induced acute dopamine depletion. Acute depletion of intrasynaptic dopamine resulted in a larger increase in D(2) receptor availability in patients with schizophrenia (19% +/- 11%) compared with control subjects (9% +/- 7%, P = 0.003). The increased occupancy of D(2) receptors by dopamine occurred both in first-episode neuroleptic-naive patients and in previously treated chronic patients experiencing an episode of illness exacerbation. In addition, elevated synaptic dopamine was predictive of good treatment response of positive symptoms to antipsychotic drugs. This finding provides direct evidence of increased stimulation of D(2) receptors by dopamine in schizophrenia, consistent with increased phasic activity of dopaminergic neurons.
Figures

Schematic presentation of the experiment. The blue rectangles represent the total population of D2 receptors. At baseline, an unknown proportion of these receptors is occupied by dopamine (shaded area), and only a fraction of receptors are unoccupied and available to [123I]IBZM binding. After α-MPT-induced depletion of endogenous dopamine, all receptors are available to [123I]IBZM binding. Thus, comparing the [123I]IBZM binding potential at baseline and after dopamine depletion allows derivation of the proportion of D2 receptors that were masked by dopamine at baseline. The SPECT images display distribution of [123I]IBZM in one subject at baseline and after dopamine depletion (note the increase in specific binding in the striatum).

Increase in [123I]IBZM BP to D2 receptors after acute dopamine depletion in controls and patients with schizophrenia (●, previously treated patients; ○, first-episode neuroleptic-naive patients).

Relationship between baseline dopamine levels, as estimated by the α-MPT effect on [123I]IBZM BP, and the decrease in positive symptoms measured after 6 weeks of antipsychotic treatments.
Comment in
-
Schizophrenia: more dopamine, more D2 receptors.
Seeman P, Kapur S. Seeman P, et al. Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7673-5. doi: 10.1073/pnas.97.14.7673. Proc Natl Acad Sci U S A. 2000. PMID: 10884398 Free PMC article. No abstract available.
Similar articles
-
Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.
Kegeles LS, Abi-Dargham A, Frankle WG, Gil R, Cooper TB, Slifstein M, Hwang DR, Huang Y, Haber SN, Laruelle M. Kegeles LS, et al. Arch Gen Psychiatry. 2010 Mar;67(3):231-9. doi: 10.1001/archgenpsychiatry.2010.10. Arch Gen Psychiatry. 2010. PMID: 20194823
-
Bloemen OJ, de Koning MB, Gleich T, Meijer J, de Haan L, Linszen DH, Booij J, van Amelsvoort TA. Bloemen OJ, et al. Eur Neuropsychopharmacol. 2013 Feb;23(2):126-32. doi: 10.1016/j.euroneuro.2012.04.015. Epub 2012 May 14. Eur Neuropsychopharmacol. 2013. PMID: 22591910 Clinical Trial.
-
Frankle WG, Gil R, Hackett E, Mawlawi O, Zea-Ponce Y, Zhu Z, Kochan LD, Cangiano C, Slifstein M, Gorman JM, Laruelle M, Abi-Dargham A. Frankle WG, et al. Psychopharmacology (Berl). 2004 Oct;175(4):473-80. doi: 10.1007/s00213-004-1852-4. Psychopharmacology (Berl). 2004. PMID: 15083259 Clinical Trial.
-
Dopamine and antipsychotic drug action revisited.
Jones HM, Pilowsky LS. Jones HM, et al. Br J Psychiatry. 2002 Oct;181:271-5. doi: 10.1192/bjp.181.4.271. Br J Psychiatry. 2002. PMID: 12356650 Review. No abstract available.
-
Mechanism of new antipsychotic medications: occupancy is not just antagonism.
Grunder G, Carlsson A, Wong DF. Grunder G, et al. Arch Gen Psychiatry. 2003 Oct;60(10):974-7. doi: 10.1001/archpsyc.60.10.974. Arch Gen Psychiatry. 2003. PMID: 14557141 Review.
Cited by
-
Howes OD, Fusar-Poli P, Bloomfield M, Selvaraj S, McGuire P. Howes OD, et al. Curr Pharm Des. 2012;18(4):459-65. doi: 10.2174/138161212799316217. Curr Pharm Des. 2012. PMID: 22239576 Free PMC article. Review.
-
Narendran R, Jedema HP, Lopresti BJ, Mason NS, Gurnsey K, Ruszkiewicz J, Chen CM, Deuitch L, Frankle WG, Bradberry CW. Narendran R, et al. Mol Psychiatry. 2014 Mar;19(3):302-10. doi: 10.1038/mp.2013.9. Epub 2013 Feb 26. Mol Psychiatry. 2014. PMID: 23439486 Free PMC article.
-
Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention.
Gomes FV, Grace AA. Gomes FV, et al. Int J Mol Sci. 2021 Apr 25;22(9):4467. doi: 10.3390/ijms22094467. Int J Mol Sci. 2021. PMID: 33922888 Free PMC article. Review.
-
Dysregulation of Midbrain Dopamine System and the Pathophysiology of Schizophrenia.
Sonnenschein SF, Gomes FV, Grace AA. Sonnenschein SF, et al. Front Psychiatry. 2020 Jun 30;11:613. doi: 10.3389/fpsyt.2020.00613. eCollection 2020. Front Psychiatry. 2020. PMID: 32719622 Free PMC article. Review.
-
Neurobiological background of negative symptoms.
Galderisi S, Merlotti E, Mucci A. Galderisi S, et al. Eur Arch Psychiatry Clin Neurosci. 2015 Oct;265(7):543-58. doi: 10.1007/s00406-015-0590-4. Epub 2015 Mar 24. Eur Arch Psychiatry Clin Neurosci. 2015. PMID: 25797499 Review.
References
-
- Bromet E J, Fennig S. Biol Psychiatry. 1999;46:871–881. - PubMed
-
- Andreasen N C, Olsen S. Arch Gen Psychiatry. 1982;39:789–794. - PubMed
-
- Gold J M, Harvey P D. Psychiatr Clin North Am. 1993;16:295–312. - PubMed
-
- Hegarty J D, Baldessarini R J, Tohen M, Waternaux C, Oepen G. Am J Psychiatry. 1994;151:1409–1416. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical